The National Agency for Food and Drugs Administration and Control (NAFDAC) has alerted the public of a counterfeit Dostinex (Cabergolin) 0.5mg tablet in circulation.
NAFDAC issued the alert on its website, following the notification received from Pfizer Specialties Limited, the manufacturer of the original product, disclosing a patient’s complaint about the product. The agency stated.
